IMUX raises €26.7M Growth round
12 April 2019· Mannheim, Germany· manufacturing, energy, robotics, b2b, software_hardware
The funding was raised concurrently with Immunic's NASDAQ listing via a reverse merger to provide sufficient financing into the third quarter of 2020.
Investors
LeadLife Sciences Partners
Also participating
High-Tech GründerfondsBayern KapitalLifeCare PartnersOmega FundsIBG Beteiligungsgesellschaft Sachsen-AnhaltFund+
About IMUX
Stage
Growth
Headquarters
Mannheim, Germany
Founded
2020
Team Size
6–20
Sectors
manufacturingenergyroboticsb2bsoftware_hardware